FERRARI, Silvia Martina
 Distribuzione geografica
Continente #
NA - Nord America 8.625
EU - Europa 2.822
AS - Asia 2.263
SA - Sud America 300
AF - Africa 40
Continente sconosciuto - Info sul continente non disponibili 5
OC - Oceania 5
Totale 14.060
Nazione #
US - Stati Uniti d'America 8.576
GB - Regno Unito 1.570
CN - Cina 770
SG - Singapore 689
HK - Hong Kong 365
SE - Svezia 262
BR - Brasile 250
DE - Germania 229
UA - Ucraina 181
TR - Turchia 172
IT - Italia 145
RU - Federazione Russa 116
FI - Finlandia 108
VN - Vietnam 86
FR - Francia 75
BG - Bulgaria 64
KR - Corea 38
ID - Indonesia 34
AR - Argentina 23
ZA - Sudafrica 23
CA - Canada 22
AE - Emirati Arabi Uniti 17
IN - India 17
ES - Italia 14
NL - Olanda 14
JP - Giappone 13
EC - Ecuador 12
IE - Irlanda 11
PL - Polonia 11
BD - Bangladesh 10
MX - Messico 10
BZ - Belize 9
IQ - Iraq 9
PK - Pakistan 8
MY - Malesia 7
CL - Cile 6
KE - Kenya 5
NP - Nepal 5
AU - Australia 4
CO - Colombia 4
EG - Egitto 4
JO - Giordania 4
LT - Lituania 4
MA - Marocco 4
AZ - Azerbaigian 3
BY - Bielorussia 3
EU - Europa 3
SA - Arabia Saudita 3
TT - Trinidad e Tobago 3
UZ - Uzbekistan 3
VE - Venezuela 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AT - Austria 2
BE - Belgio 2
CH - Svizzera 2
HN - Honduras 2
HU - Ungheria 2
IR - Iran 2
PS - Palestinian Territory 2
RO - Romania 2
TN - Tunisia 2
AM - Armenia 1
BH - Bahrain 1
BO - Bolivia 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
CZ - Repubblica Ceca 1
DO - Repubblica Dominicana 1
IL - Israele 1
IS - Islanda 1
JM - Giamaica 1
KZ - Kazakistan 1
LU - Lussemburgo 1
MN - Mongolia 1
PT - Portogallo 1
SK - Slovacchia (Repubblica Slovacca) 1
TH - Thailandia 1
TV - Tuvalu 1
UY - Uruguay 1
ZM - Zambia 1
Totale 14.060
Città #
Southend 1.275
Fairfield 911
Santa Clara 759
Woodbridge 589
Ashburn 587
Chicago 474
Singapore 424
Jacksonville 387
Hong Kong 365
Houston 352
Seattle 334
Los Angeles 303
Chandler 296
Cambridge 282
Wilmington 278
Dearborn 225
Ann Arbor 217
Salt Lake City 205
Hefei 194
Nyköping 184
London 167
Beijing 133
Izmir 113
Tampa 93
Elk Grove Village 92
Princeton 70
San Diego 65
Sofia 64
Bremen 62
Modena 60
Eugene 58
Helsinki 51
New York 49
Sterling 48
Council Bluffs 47
Dallas 47
Lancaster 43
Buffalo 41
Seoul 38
Shanghai 33
The Dalles 33
Moscow 31
Dulles 29
Miami 29
Ho Chi Minh City 28
Columbus 27
Frankfurt am Main 27
Jakarta 27
Detroit 26
São Paulo 26
Des Moines 25
Atlanta 23
Hanoi 23
Phoenix 18
San Jose 18
Redwood City 17
Dong Ket 14
Kansas City 14
Milan 14
Kunming 13
Boardman 12
Guangzhou 12
Norwalk 12
Chiswick 11
Dublin 11
Pittsburgh 11
Warsaw 11
Brooklyn 10
Curitiba 10
Hounslow 10
Tokyo 10
Belize City 9
Hangzhou 9
Kilburn 9
Jersey City 8
Montreal 8
Johannesburg 7
Redondo Beach 7
San Francisco 7
Toronto 7
Belo Horizonte 6
Mountain View 6
Saint Louis 6
Tianjin 6
Acton 5
Amsterdam 5
Baltimore 5
Campinas 5
Chengdu 5
Delhi 5
Denver 5
Falls Church 5
Fuzhou 5
Indiana 5
Jiaxing 5
Jinan 5
Nanjing 5
Quito 5
Rio de Janeiro 5
Serra 5
Totale 10.772
Nome #
Thyroid Involvement in Hepatitis C Virus-Infected Patients with/without Mixed Cryoglobulinemia 737
Chemokine (C-X-C motif) ligand (CXCL)10 in autoimmune diseases. 374
Endocrine manifestations of hepatitis C virus infection. 338
Hepatitis C virus infection and type 1 and type 2 diabetes mellitus 336
High values of CXCL10 serum levels in patients with hepatitis C associated mixed cryoglobulinemia in presence or absence of autoimmune thyroiditis 327
CXCL10 (α) and CCL2 (β) chemokines in systemic sclerosis - A longitudinal study 322
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up. 320
CXCL10 and CCL2 serum levels in patients with mixed cryoglobulinaemia and hepatitis C. 313
Circulating CXCL11 and CXCL10 are increased in hepatitis C-associated cryoglobulinemia in the presence of autoimmune thyroiditis. 310
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C. 305
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 301
High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia 293
Targeting chemokine (C-X-C motif) receptor 3 in thyroid autoimmunity 282
High circulating levels of N-terminal pro-brain natriuretic peptide and interleukin 6 in patients with mixed cryoglobulinemia 279
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection, and HCV extrahepatic manifestations 278
N-Terminal Pro-Brain Natriuretic Peptide and Tumor Necrosis Factor-alpha Both Are Increased in Patients With Hepatitis C 274
Clinical and subclinical autoimmune thyroid disorders insystemic sclerosis 273
Cytokines and HCV-related disorders 263
High circulating chemokines (C-X-C motif) ligand 9, and (C-X-C motif) ligand 11, in hepatitis C-associated cryoglobulinemia. 261
Modulatory effects of peroxisome proliferator-activated receptor-γ on CXCR3 chemokines 261
Application of Agents Against Interferon-Gamma-Dependent Chemokines in Immunotherapy 255
Induction of CXCL10 secretion by interferon-γ and tumour necrosis factor-α and its inhibition by peroxisome proliferator-activated receptor-γ agonists in cultured scleroderma fibroblasts. 254
Autoimmune and neoplastic thyroid diseases associated with hepatitis C chronic infection 253
Serum concentrations of interleukin 1beta, CXCL10, and interferon-gamma in mixed cryoglobulinemia associated with hepatitis C infection 251
Associations between Systemic Sclerosis and Thyroid Diseases 245
New targeted molecular therapies for dedifferentiated thyroid cancer 238
CXCL10 and CCL2 Chemokine Serum Levels in Patients With Hepatitis C Associated With Autoimmune Thyroiditis 231
Endocrine Manifestations of HCV-Positive Cryoglobulinemia 228
HEPATITIS C IS ASSOCIATED WITH HIGH LEVELS OF CIRCULATING N-TERMINAL PRO-BRAIN NATRIURETIC PEPTIDE AND INTERLEUKIN-6 221
Interferon-α, -β and -γ induce CXCL11 secretion in human thyrocytes: modulation by peroxisome proliferator-activated receptor γ agonists. 213
Parallel increase of circulating CXCL11 and CXCL10 in mixed cryoglobulinemia, while the proinflammatory cytokine IL-6 is associated with high serum Th2 chemokine CCL2 213
High values of CXCL10 serum levels in mixed cryoglobulinemia associated with hepatitis C infection 212
IP-10 in autoimmune thyroiditis 211
Novel Therapies for Thyroid Autoimmune Diseases 211
[CXCR3 and CXCL10 in autoimmune thyroiditis] 205
High Levels of Circulating Chemokine (C-X-C motif) Ligand 11 Are Associated with Euthyroid or Subclinically Hypothyroid Autoimmune Thyroiditis and with Chemokine (C-X-C Motif) Ligand 10 197
[Cryoglobulinemia and the α-chemokine IP-10] 197
Chemokine (CXC motif) ligand 9 serum levels in mixed cryoglobulinemia are associated with circulating levels of IFN-γ and TNF-α 196
The presence of autoimmune thyroiditis in mixed cryoglobulinemia patients is associated with high levels of circulating interleukin-6, but not of tumor necrosis factor-alpha. 195
COVID-19 and systemic sclerosis: clinicopathological implications from Italian nationwide survey study 194
Thyroid involvement in hepatitis C - associated mixed cryoglobulinemia 191
CXCL10 in psoriasis 190
Incidence of thyroid disorders in mixed cryoglobulinemia: Results from a longitudinal follow-up 190
PATIENTS WITH MIXED CRYOGLOBULINEMIA AND HCV INFECTION, IN PRESENCE OR ABSENCE OF AUTOIMMUNE THYROIDITIS, HAVE HIGH SERUM LEVELS OF (CXC MOTIF) LIGAND (CXCL)9 AND CXCL11 CHEMOKINES 188
RET TKI: potential role in thyroid cancers. 181
α-Chemokine CXCL10 and β-chemokine CCL2 serum levels in patients with hepatitis C-associated cryoglobulinemia in the presence or absence of autoimmune thyroiditis 178
Interleukin-1beta, C-X-C Motif Ligand 10, and Interferon-Gamma Serum Levels in Mixed Cryoglobulinemia With or Without Autoimmune Thyroiditis. 165
Increased CXCL9 serum levels in hepatitis C-related mixed cryoglobulinemia, with autoimmune thyroiditis, associated with high levels of CXCL10. 163
Role of CXCL10 in cryoglobulinemia 157
Extrahepatic manifestations of hepatitis C virus: the thyroid disorders 156
Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2. 152
Peroxisome proliferator-activated receptor γ agonists reduce cell proliferation and viability and increase apoptosis in systemic sclerosis fibroblasts 152
High serum levels of CXCL11 in mixed cryoglobulinemia are associated with increased circulating levels of interferon-γ. 148
Type 1 diabetes and (C-X-C motif) ligand (CXCL) 10 chemokine 139
Immunomodulation of CXCL10 secretion by hepatitis C virus: Could CXCL10 be a prognostic marker of chronic hepatitis C? 136
Serum levels of proinflammatory cytokines interleukin-1beta, interleukin-6, and tumor necrosis factor alpha in mixed cryoglobulinemia 135
Increased risk of papillary thyroid cancer in systemic sclerosis associated with autoimmune thyroiditis 133
High circulating N-terminal pro-brain natriuretic peptide and tumor necrosis factor-alpha in mixed cryoglobulinemia 127
HCV-related autoimmune disorders in HCV chronic infection. 122
Mixed cryoglobulinemia and thyroid autoimmune disorders 112
Hepatitis C virus infection and type 2 diabetes. 101
Fatigue in patients with systemic sclerosis and hypothyroidism. A review of the literature and report of our experience 93
Totale 14.176
Categoria #
all - tutte 68.724
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 68.724


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20211.214 0 0 0 0 0 222 175 329 86 167 151 84
2021/20221.135 53 154 194 68 8 55 72 41 96 90 190 114
2022/2023980 153 76 81 74 151 139 19 103 110 7 45 22
2023/2024640 12 37 38 120 158 25 45 62 12 37 31 63
2024/20252.262 64 13 19 188 529 376 73 124 286 205 188 197
2025/20263.514 177 144 295 958 1.690 250 0 0 0 0 0 0
Totale 14.176